Exploring how metabolic gene expression in circulating tumor cells from early-stage non-small cell lung cancer patients could transform detection and treatment.
Discover how genetic polymorphisms in DNA repair and xenobiotic biotransformation enzyme genes influence lung cancer risk among coal mine workers.
Explore the groundbreaking research on T lymphocyte rehabilitation in lung cancer treatment, including mitochondrial transfer and innovative immunotherapies.
Discover how chaetocin, a natural compound from fungi, shows promise in fighting drug-resistant non-small cell lung cancer by targeting transketolase and metabolic pathways.
Exploring how galectin-1 acts as a molecular bodyguard for CD133+ cancer stem cells in lung adenocarcinoma and its potential as a therapeutic target.